NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,008 filers reported holding NOVARTIS A G in Q4 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $596,883 | +84.2% | 5,915 | +65.6% | 0.17% | +29.2% |
| Q4 2022 | $324,052 | -54.0% | 3,572 | -61.5% | 0.13% | -52.6% |
| Q3 2022 | $704,000 | +12.8% | 9,266 | +25.5% | 0.27% | -12.2% |
| Q2 2022 | $624,000 | +74.3% | 7,386 | +88.4% | 0.31% | -4.3% |
| Q2 2021 | $358,000 | +72.1% | 3,920 | +64.4% | 0.33% | +18.5% |
| Q2 2020 | $208,000 | -55.0% | 2,385 | -55.1% | 0.28% | -34.7% |
| Q3 2019 | $462,000 | -13.5% | 5,316 | -14.5% | 0.42% | +48.8% |
| Q4 2018 | $534,000 | -6.0% | 6,219 | -5.7% | 0.28% | +14.1% |
| Q3 2018 | $568,000 | +50.3% | 6,594 | +49.9% | 0.25% | +131.8% |
| Q3 2017 | $378,000 | -3.6% | 4,400 | -6.4% | 0.11% | -21.3% |
| Q2 2017 | $392,000 | +30.7% | 4,700 | +23.7% | 0.14% | -23.2% |
| Q3 2016 | $300,000 | -40.4% | 3,800 | -37.7% | 0.18% | -27.5% |
| Q2 2016 | $503,000 | +73.4% | 6,100 | +52.5% | 0.24% | +25.8% |
| Q1 2016 | $290,000 | – | 4,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |